AUTOLOGOUS NEUTRALIZING ANTIBODIES PREVAIL IN HIV-2 BUT NOT IN HIV-1 INFECTION

被引:74
作者
BJORLING, E
SCARLATTI, G
VONGEGERFELT, A
ALBERT, J
BIBERFELD, G
CHIODI, F
NORRBY, E
FENYO, EM
机构
[1] KAROLINSKA INST, DEPT VIROL, S-10521 STOCKHOLM, SWEDEN
[2] NATL BACTERIOL LAB, DEPT VIROL, S-10521 STOCKHOLM, SWEDEN
[3] NATL BACTERIOL LAB, DEPT IMMUNOL, S-10521 STOCKHOLM, SWEDEN
关键词
D O I
10.1006/viro.1993.1160
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type 2 (HIV-2) has been reported to be less pathogenic than HIV-1. We have investigated the capacity of sera from nine HIV-2-infected individuals to neutralize their own autologous virus. All nine HIV-2-infected individuals neutralized autologous virus with titers ranging between 20 and 320. In contrast, we have previously reported that most HIV-1-infected individuals lack such antibodies. The difference between HIV-1 and HIV-2 infection was statistically significant (P < 0.0002, Pearson test) and the difference in neutralizing antibody prevalence may explain the faster disease progression in HIV-1-infected individuals than in HIV-2-infected individuals. © 1993 Academic Press, Inc.
引用
收藏
页码:528 / 530
页数:3
相关论文
共 22 条
  • [1] RAPID DEVELOPMENT OF ISOLATE-SPECIFIC NEUTRALIZING ANTIBODIES AFTER PRIMARY HIV-1 INFECTION AND CONSEQUENT EMERGENCE OF VIRUS VARIANTS WHICH RESIST NEUTRALIZATION BY AUTOLOGOUS SERA
    ALBERT, J
    ABRAHAMSSON, B
    NAGY, K
    AURELIUS, E
    GAINES, H
    NYSTROM, G
    FENYO, EM
    [J]. AIDS, 1990, 4 (02) : 107 - 112
  • [2] REPLICATIVE CAPACITY OF HIV-2, LIKE HIV-1, CORRELATES WITH SEVERITY OF IMMUNODEFICIENCY
    ALBERT, J
    NAUCLER, A
    BOTTIGER, B
    BROLIDEN, PA
    ALBINO, P
    OUATTARA, SA
    BJORKEGREN, C
    VALENTIN, A
    BIBERFELD, G
    FENYO, EM
    [J]. AIDS, 1990, 4 (04) : 291 - 295
  • [3] ARENDRUP M, 1992, J ACQ IMMUN DEF SYND, V5, P303
  • [4] ASJO B, 1986, LANCET, V2, P660
  • [5] INVIVO GENETIC-VARIABILITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 V3-REGION
    BOERI, E
    GIRI, A
    LILLO, F
    FERRARI, G
    VARNIER, OE
    FERRO, A
    SABBATANI, S
    SAXINGER, WC
    FRANCHINI, G
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (07) : 4546 - 4550
  • [6] BOLOGNESI DP, 1988, MICROBIOL SCI, V5, P236
  • [7] BOTTIGER B, 1990, J VIROL, V64, P3492
  • [8] A COMPARISON OF HIV-1 AND HIV-2 INFECTIONS IN HOSPITALIZED-PATIENTS IN ABIDJAN, IVORY-COAST
    DECOCK, KM
    ODEHOURI, K
    COLEBUNDERS, RL
    ADJORLOLO, G
    LAFONTAINE, MF
    PORTER, A
    GNAORE, E
    DIABY, L
    MOREAU, J
    HEYWARD, WL
    [J]. AIDS, 1990, 4 (05) : 443 - 448
  • [9] ANTIBODY-MEDIATED INVITRO NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ABOLISHES INFECTIVITY FOR CHIMPANZEES
    EMINI, EA
    NARA, PL
    SCHLEIF, WA
    LEWIS, JA
    DAVIDE, JP
    LEE, DR
    KESSLER, J
    CONLEY, S
    MATSUSHITA, S
    PUTNEY, SD
    GERETY, RJ
    EICHBERG, JW
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (08) : 3674 - 3678
  • [10] HUMAN INFECTION BY GENETICALLY DIVERSE SIVSM-RELATED HIV-2 IN WEST AFRICA
    GAO, F
    YUE, L
    WHITE, AT
    PAPPAS, PG
    BARCHUE, J
    HANSON, AP
    GREENE, BM
    SHARP, PM
    SHAW, GM
    HAHN, BH
    [J]. NATURE, 1992, 358 (6386) : 495 - 499